Eribulin mesylate in the treatment of metastatic breast cancer

Sarika Jain, Tessa CiglerDepartment of Medicine, Weill Cornell Medical College, New York, NY, USAAbstract: The treatment of metastatic breast cancer (MBC) has become increasingly challenging as the primary goals of therapy include prolonging life without added toxicity. While multiple agents are app...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jain S, Cigler T
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://doaj.org/article/e4b6daa81e6f4cc294aa1d0945c94463
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!